Background and Aim: A tendency to metabolic acidosis with use of amino acid-based peritoneal dialysis solution, especially when two exchanges are performed with the solutions. In the present study, we aimed to investigate whether metabolic acidosis is a considerable problem in patients on continuous ambulatory peritoneal dialysis (CAPD) used amino acid-based peritoneal dialysis solution.

Method: The cross-sectional study included 119 PD (62 female, 57 male) patients. The first group consisted of 47 patients who had used amino acid-based PD solution once a day. The second group included 72 patients who had not used the solution.

Results: Mean age was 47 ± 13 years. Blood bicarbonate concentration and serum albumin level were significantly lower in first group than that of the second group (25.12 ± 3.38 mmol/L vs. 26.91 ± 4.32 mmol/L, P: 0.018 and 2.82 ± 0.46 g/dL vs. 3.15 ± 0.50 g/dL, P: 0.001, respectively). On the other hand, blood urea nitrogen concentration and use of essential amino acid preparation were meaningfully higher in the first group than those of the second group (66.17 ± 13.70 mg/dL vs. 52.79 ± 16.55 mg/dL, P: 0.001 and 33 (47.8%) patients vs. 14 (28%) patients, P: 0.022, respectively). However, there was no meaningfully difference between these groups for serum pH value and presence of metabolic acidosis.

Conclusion: Although mean blood bicarbonate concentration was significantly lower in amino acid-based PD solution group than that of the control group, it was in normal range in both groups and there was no significant difference between both groups for pH value and presence of metabolic acidosis. Therefore, metabolic acidosis is not a considerable problem in PD patients used amino acid-based peritoneal dialysis solution.

"/> Background and Aim: A tendency to metabolic acidosis with use of amino acid-based peritoneal dialysis solution, especially when two exchanges are performed with the solutions. In the present study, we aimed to investigate whether metabolic acidosis is a considerable problem in patients on continuous ambulatory peritoneal dialysis (CAPD) used amino acid-based peritoneal dialysis solution.

Method: The cross-sectional study included 119 PD (62 female, 57 male) patients. The first group consisted of 47 patients who had used amino acid-based PD solution once a day. The second group included 72 patients who had not used the solution.

Results: Mean age was 47 ± 13 years. Blood bicarbonate concentration and serum albumin level were significantly lower in first group than that of the second group (25.12 ± 3.38 mmol/L vs. 26.91 ± 4.32 mmol/L, P: 0.018 and 2.82 ± 0.46 g/dL vs. 3.15 ± 0.50 g/dL, P: 0.001, respectively). On the other hand, blood urea nitrogen concentration and use of essential amino acid preparation were meaningfully higher in the first group than those of the second group (66.17 ± 13.70 mg/dL vs. 52.79 ± 16.55 mg/dL, P: 0.001 and 33 (47.8%) patients vs. 14 (28%) patients, P: 0.022, respectively). However, there was no meaningfully difference between these groups for serum pH value and presence of metabolic acidosis.

Conclusion: Although mean blood bicarbonate concentration was significantly lower in amino acid-based PD solution group than that of the control group, it was in normal range in both groups and there was no significant difference between both groups for pH value and presence of metabolic acidosis. Therefore, metabolic acidosis is not a considerable problem in PD patients used amino acid-based peritoneal dialysis solution.

"/>

Is Metabolic Acidosis a Considerable Problem in Peritoneal Dialysis Patients when Amino Acid-Based Peritoneal Dialysis Solution is Used?

AUTHORS

Aydin Unal 1 , * , Ismail Kocyigit 2 , Murat H Sipahioglu 2 , Bulent Tokgoz 2 , Oktay Oymak 2 , Cengiz Utas 2

1 Department of Nephrology, Erciyes University Medical School, [email protected], Turkey

2 Department of Nephrology, Erciyes University Medical School, Turkey

How to Cite: Unal A, Kocyigit I, Sipahioglu M, Tokgoz B, Oymak O, et al. Is Metabolic Acidosis a Considerable Problem in Peritoneal Dialysis Patients when Amino Acid-Based Peritoneal Dialysis Solution is Used?, Nephro-Urol Mon. Online ahead of Print ; 3(1):41-45.

ARTICLE INFORMATION

Nephro-Urology Monthly: 3 (1); 41-45
Article Type: Research Article
Received: November 2, 2009
Accepted: November 15, 2009
READ FULL TEXT

Abstract

Background and Aim: A tendency to metabolic acidosis with use of amino acid-based peritoneal dialysis solution, especially when two exchanges are performed with the solutions. In the present study, we aimed to investigate whether metabolic acidosis is a considerable problem in patients on continuous ambulatory peritoneal dialysis (CAPD) used amino acid-based peritoneal dialysis solution.

Method: The cross-sectional study included 119 PD (62 female, 57 male) patients. The first group consisted of 47 patients who had used amino acid-based PD solution once a day. The second group included 72 patients who had not used the solution.

Results: Mean age was 47 ± 13 years. Blood bicarbonate concentration and serum albumin level were significantly lower in first group than that of the second group (25.12 ± 3.38 mmol/L vs. 26.91 ± 4.32 mmol/L, P: 0.018 and 2.82 ± 0.46 g/dL vs. 3.15 ± 0.50 g/dL, P: 0.001, respectively). On the other hand, blood urea nitrogen concentration and use of essential amino acid preparation were meaningfully higher in the first group than those of the second group (66.17 ± 13.70 mg/dL vs. 52.79 ± 16.55 mg/dL, P: 0.001 and 33 (47.8%) patients vs. 14 (28%) patients, P: 0.022, respectively). However, there was no meaningfully difference between these groups for serum pH value and presence of metabolic acidosis.

Conclusion: Although mean blood bicarbonate concentration was significantly lower in amino acid-based PD solution group than that of the control group, it was in normal range in both groups and there was no significant difference between both groups for pH value and presence of metabolic acidosis. Therefore, metabolic acidosis is not a considerable problem in PD patients used amino acid-based peritoneal dialysis solution.

Full Text

Full text is available in PDF

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
COMMENTS

LEAVE A COMMENT HERE: